Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$497K Sell
10,958
-20,747
-65% -$916K 0.01% 1148
2017
Q1
$1.35M Buy
31,705
+422
+1% +$17.2K 0.04% 499
2016
Q4
$1.25M Sell
31,283
-4,180
-12% -$161K 0.03% 585
2016
Q3
$1.38M Buy
35,463
+2,038
+6% +$76.9K 0.03% 493
2016
Q2
$1.16M Sell
33,425
-37,245
-53% -$1.29M 0.02% 651
2016
Q1
$2.44M Buy
70,670
+45,857
+185% +$1.6M 0.07% 208
2015
Q4
$960K Buy
24,813
+17,898
+259% +$696K 0.02% 898
2015
Q3
$271K Buy
+6,915
New +$274K ﹤0.01% 2200
2015
Q1
Sell
-15,871
Closed -$424K 3436
2014
Q4
$424K Sell
15,871
-17,527
-52% -$452K 0.01% 1900
2014
Q3
$812K Sell
33,398
-3,443
-9% -$86.9K 0.02% 1157
2014
Q2
$934K Buy
+36,841
New +$861K 0.01% 1240
2014
Q1
Sell
-30,462
Closed -$680K 3739
2013
Q4
$680K Buy
30,462
+3,452
+13% +$76.1K 0.01% 1601
2013
Q3
$557K Buy
+27,010
New +$575K 0.01% 1878

Other funds holding HOLX

Virtu KCG Holdings's HOLX Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Hologic (HOLX) stake by 65% in Q2 2017, selling an estimated $916K and leaving 10,958 shares worth $497K. The position accounts for 0.01% of the portfolio, ranked #1148.

Virtu KCG Holdings first reported a position in HOLX in Q3 2013 and has held it in 13 quarters since. The position peaked at $2.44M in Q1 2016. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Virtu KCG Holdings held 10,958 shares of Hologic worth $497K as of Q2 2017.
  • Virtu KCG Holdings sold 20,747 Hologic shares in Q2 2017, an estimated $916K.
  • Hologic made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1148 holding.
  • Virtu KCG Holdings first reported a position in Hologic in Q3 2013 and has held it in 13 quarters since.
  • Virtu KCG Holdings's Hologic position peaked at $2.44M in Q1 2016.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.